Research Article
The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET
Table 2
Bone marrow toxicity of [90Y]Y/[177Lu]Lu-DOTATATE.
| | PRRT (n = 26) | n (%) | | HgB1 | 2 (7.7) | | HgB1, transient, WBC1 | 1 (3.8) | | HgB1, WBC1 | 2 (7.7) | | HgB2, transient | 1 (3.8) | | WBC1 | 2 (7.7) | | WBC2, transient | 1 (3.8) | | WBC1, PLT1, transient | 2 (7.7) |
| | R-PRRT (n = 26) | | | HgB1 | 9 (34.6) | | HgB1, WBC1 | 2 (7.7) | | HgB1, WBC1, PLT1 | 2 (7.7) | | HgB2 | 2 (7.7) | | WBC1, transient | 1 (3.8) | | WBC1, PLT1 | 1 (3.8) | | WBC2 | 2 (7.7) |
| | RR-PRRT (n = 5) | | | HgB1 | 3 | | HgB2 | 1 | | MDS | 1 |
|
|
